Adults up aged 70 and, people that have hearing loss had been 21 % to 39 % more likely to die over another several years. Experts stressed that the findings, published in the Sept. 24 online edition of JAMA Otolaryngology-Head & Neck Medical procedures, do not demonstrate that hearing impairment, itself, shortens people’s lives. This is a fascinating observation, but it also must be taken with a grain of salt, said Dr. Ana Kim, director of otology research at the brand new York Eye and Ear Infirmary of Mount Sinai, in New York City, who was not mixed up in research. There are so many variables that get into mortality, she said.Kenneth Weissmahr feedback, The very encouraging non-clinical data is displaying the potential of Acadra in Multiple Myeloma and Mantle Cell Lymphoma which raises substantially the market potential of this drug. These outcomes validate our business model and now we look forward to partner the program with a firm that guarantees its advancement to market. Acadra was in-licensed by Advancell from the University of Barcelona until November 2009, when the Spanish biotech licensed-back its rights from BTG.
5th Digital Pharma & Life Sciences Meeting with Exhibition Organized by Microsoft and Partners february 2010 10, Kurhaus Wiesbaden, Germany.